Harmine

Harmine

SCHEMBL292955

COc1ccc2c(c1)[nH]c1c(C)nccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 11/20 1.00
DYRK1A Q13627 10/20 1.00
ACHE P22303 2/20 1.00
CCNB2 O95067 2/20 1.00
CDK1 P06493 2/20 1.00
CCNB1 P14635 2/20 1.00
CCNA2 P20248 2/20 1.00
CDK2 P24941 2/20 1.00
CCNA1 P78396 2/20 1.00
CDK5 Q00535 2/20 1.00
CDK5R1 Q15078 2/20 1.00
CCNB3 Q8WWL7 2/20 1.00
KDM4E B2RXH2 1/20 1.00
DYRK3 O43781 1/20 1.00
CCNT1 O60563 1/20 1.00
ALDH1A1 P00352 1/20 1.00
CYP1A2 P05177 1/20 1.00
CYP3A4 P08684 1/20 1.00
ADRA2A P08913 1/20 1.00
CYP2D6 P10635 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Harmine SCHEMBL29440552 1.00 MAOA (1.00) MAOADYRK1AACHECCNB2CDK1
Harmine SCHEMBL30510974 1.00 MAOA (1.00) MAOADYRK1AACHECCNB2CDK1
Harmine SCHEMBL9481427 1.00 MAOA (1.00) MAOADYRK1AACHECCNB2CDK1
Harmine SCHEMBL29941920 1.00 MAOA (1.00) MAOADYRK1AACHECCNB2CDK1
Harmine SCHEMBL1469013 0.98 KLK7 (1.00) MAOADYRK1AACHECCNB2CDK1
Harmine SCHEMBL16099771 0.98 MAOA (0.97) MAOADYRK1AACHECCNB2CDK1
Harmine SCHEMBL30726913 0.98 KLK7 (1.00) MAOADYRK1AACHECCNB2CDK1
Harmine SCHEMBL31500130 0.97 KLK7 (0.97) MAOADYRK1AACHECCNB2CDK1
Harmine SCHEMBL669625 0.97 KLK7 (0.97) MAOADYRK1AACHECCNB2CDK1
Harmine SCHEMBL4907423 0.97 KLK7 (0.97) MAOADYRK1AACHECCNB2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 5014 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260137652-A1 Composition Comprising Non-Phosphorylated Tryptamine SINTALICA S R L (IT) 2026-05-21 US claimed
US-12630803-B2 Method of increasing proliferation of pancreatic beta cells, treatment method, and composition ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2026-05-19 US claimed
US-20260091047-A1 THERAPEUTIC COMBINATIONS FOR MOVEMENT DISORDERS NATIVE CODE BIO LLC (US) 2026-04-02 US claimed
EP-4351506-B1 LIPID CRYSTALLINE COMPOSITIONS WITH ENHANCED STABILITY FOR TOPICAL DELIVERY OF ACTIVE AGENT COMBINATIONS ANKH LIFE SCIENCES LTD (IE) 2026-04-01 EP claimed
EP-4717479-A2 SELECTING DIFFERENT SUSPENSION TUNES VIA A MANUALLY OPERATED SWITCH Fox Factory, Inc. (US) 2026-04-01 EP claimed
US-12558358-B2 N-(furan-2-ylmethyl)-7H-purin-6-amine for treatment of circadian rhythm diseases, disorders and dysfunctions UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2026-02-24 US claimed
US-20260007643-A1 HIGHLY SOLUBLE FORMULATIONS OF HARMINE RECONNECT LABS AG (CH) 2026-01-08 US claimed
US-20250339403-A1 Tryptamine Formulations and Uses Thereof Natural MedTech Pty Ltd (AU) 2025-11-06 US claimed
US-20250339483-A1 EXTRACELLULAR VESICLES FROM MICROALGAE, THEIR BIODISTRIBUTION UPON INTRANASAL ADMINISTRATION, AND USES THEREOF AGS THERAPEUTICS SAS (FR) 2025-11-06 US claimed
US-20250304688-A1 Methods and Compositions Comprising Anti-CD3 Antibodies and DYRK1A Inhibitors for Treating Diabetes PROVENTION BIO, INC. (US) 2025-10-02 US claimed
WO-2005053703-A1 COMBINATION THERAPY FOR DEMENTIA, DEPRESSION AND APATHY SHELDON LESLIE JAMES (CA) 2005-06-16 WO claimed
US-20040266637-A1 Aqueous buffered fluoride-containing etch residue removers and cleaners VERSUM MATERIALS US, LLC 2004-12-30 US claimed
CN-1542015-A Preparation method and application of harmel seed alkaloid 河北以岭医药研究院有限公司 2004-11-03 CN claimed
EP-1336602-A1 Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases Scaramuzzino, Giovanni (IT) 2003-08-20 EP claimed
US-20020102246-A1 Antimicrobial compositions NOVOZYMES A/S (DK) 2002-08-01 US claimed
US-20020019421-A1 Compositions and therapy for substance addiction BIBERMAN RONI (IL) 2002-02-14 US claimed
WO-2001084937-A1 OXIDOREDUCTASE MEDIATED ANTIMICROBIAL ACTIVITY NOVOZYMES A/S (DK) 2001-11-15 WO claimed
US-5591738-A Method of treating chemical dependency using β-carboline alkaloids, derivatives and salts thereof NDA INTERNATIONAL, INC. (US) 1997-01-07 US claimed
WO-1991014184-A1 BETA CARBOLINES AS VITAL STAINS FOR NEUROTRANSMITTER SYSTEMS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1991-09-19 WO claimed
CN-1034135-A The preparation method of peganum harmala seed extract HOSPITAL NO 2 ATTACHED TO XINJ (CN) 1989-07-26 CN claimed